I'm sure no insiders managed to sell high after earnings report knowing a PO would be coming barely a week or two later LOL...
even with the SEC watching PPL have relatives after all...
But here is good news, hope for the suckers who got left Long holding the bag:
GALE might be a take-over/ merger target given what's happening in the industry, they all need money and clout, and its low PPS now relative to the target, generally about $5.00:
Here are the 10 health-care stocks with the greatest 12-month upside implied by analysts' price targets:
Company Ticker Closing price - March 13 Consensus price target Implied 12-month upside potential
Cytori Therapeutics Inc. US:CYTX $1.20 $5.67 372%
NeoStem Inc. US:NBS $4.03 $17.00 322%
Synta Pharmaceuticals Corp. US:SNTA $2.32 $8.75 277%
Galena Biopharma Inc. US:GALE $1.42 $5.14 262%
Stemline Therapeutics Inc. US:STML $16.01 $51.00 219%
from:
UPDATE: Investors in health-care stocks get rich as M&A booms
2 hours 30 minutes ago - DJNF
By Philip van Doorn, MarketWatch
Deal premiums rise as takeover battles become common
Bind Therapeutics Inc. US:BIND $5.11 $16.00 213%
Inovio Pharmaceuticals Inc. US:INO $7.04 $22.00 213%
Peregrine Pharmaceuticals Inc. US:PPHM $1.40 $4.17 198%
Alcobra Ltd. US:ADHD $6.40 $18.67 192%
CTI BioPharma Corp. US:CTIC $1.97 $5.70 189%
Sources: Nasdaq, FactSet
